| |
|
|
|
Caladrius Biosciences- Inc.  
|
|
6.61 2.66 (0.67%) |
06-19 16:00 |
|
Open: |
4.15 |
Pre close: |
3.95 |
Target:
|
7.99 
|
|
High: |
6.8399 |
Low: |
4.1 |
Resistance:
|
6.84
7.99
|
|
Volume: |
3,270,740 |
Market Cap: |
63M |
Support:
|
4.93
3.75
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.55
|
MACD |
MACD(12,26):
|
0.14 |
|
MA(20): |
4.10 |
Signal(12,26,9): |
-0.06 |
|
MA(100): |
4.59 |
Stochastic Oscillator |
%K(14,3):
|
73.78 |
|
MA(250): |
4.10 |
%D(3): |
73.35 |
|
Average Volume(K) |
3-Month: |
8009
|
52-Week |
High:
|
6.84 |
|
10-Days: |
35885 |
Low: |
2.63 |
|
RSI |
RSI(14):
|
86.75 |
Change(%): |
55.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.180 |
Return on Equity (ttm) |
122.5 |
Shares Out. (M) |
9.57 |
|
EPS Est. Current Year |
-2.420 |
Return on Assets (ttm) |
48.5 |
Shares Float (M) |
1.71 |
|
EPS Est. Next Year |
-2.950 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.770 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
5.40 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
9 |
|
Book Value (p.s.) |
0.850 |
EBITDA (p.s.) |
-1.418 |
P/E |
-3.03 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
7.78 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
